loadpatents
name:-0.036104202270508
name:-0.05107307434082
name:-0.003835916519165
Fawzi; Mahdi B. Patent Filings

Fawzi; Mahdi B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fawzi; Mahdi B..The latest application filed is for "formulations for parenteral delivery of compounds and uses thereof".

Company Profile
4.49.35
  • Fawzi; Mahdi B. - Morristown NJ
  • - Morristown NJ US
  • Fawzi, Mahdi B. - Flanders NJ
  • Fawzi; Mahdi B. - Road Flanders NJ
  • Fawzi; Mahdi B. - Fairfield OH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Formulations For Parenteral Delivery Of Compounds And Uses Thereof
App 20220023200 - Shah; Syed M. ;   et al.
2022-01-27
Formulations For Parenteral Delivery Of Compounds And Uses Thereof
App 20200179270 - Shah; Syed M. ;   et al.
2020-06-11
Tigecycline compositions and methods of preparation
Grant 10,588,975 - Fawzi , et al.
2020-03-17
Formulations for parenteral delivery of compounds and uses thereof
Grant 10357449 -
2019-07-23
Tigecycline Compositions And Methods Of Preparation
App 20170266290 - FAWZI; Mahdi B. ;   et al.
2017-09-21
Tigecycline compositions and methods of preparation
Grant 9,694,078 - Fawzi , et al. July 4, 2
2017-07-04
Formulations For Parenteral Delivery Of Compounds And Uses Thereof
App 20160338946 - Shah; Syed M. ;   et al.
2016-11-24
Tigecycline Compositions And Methods Of Preparation
App 20160144036 - FAWZI; Mahdi B. ;   et al.
2016-05-26
Tigecycline compositions and methods of preparation
Grant 9,254,328 - Fawzi , et al. February 9, 2
2016-02-09
Tigecycline Compositions And Methods Of Preparation
App 20150141379 - Fawzi; Mahdi B. ;   et al.
2015-05-21
Tigecycline compositions and methods of preparation
Grant 8,975,242 - Fawzi , et al. March 10, 2
2015-03-10
Formulations For Parenteral Delivery Of Compounds And Uses Thereof
App 20150025100 - Shah; Syed M. ;   et al.
2015-01-22
Compositions containing piperacillin and tazobactam useful for injection
Grant 8,133,883 - Cohen , et al. March 13, 2
2012-03-13
Phosphate Derivatives of Substituted Benzoxazoles
App 20110212923 - Baudy; Reinhardt ;   et al.
2011-09-01
Tigecycline Compositions and Methods of Preparation
App 20110118216 - Fawzi; Mahdi B. ;   et al.
2011-05-19
Tigecycline compositions and methods of preparation
Grant 7,879,828 - Fawzi , et al. February 1, 2
2011-02-01
Formulations For Parenteral Delivery Of Compounds And Uses Thereof
App 20100249169 - Shah; Syed M. ;   et al.
2010-09-30
O-desmethylvenlafaxine And Bazedoxifene Combination Product And Uses Thereof
App 20100221445 - Shah; Syed M. ;   et al.
2010-09-02
Sustained-release formulation and uses thereof
Grant 7,709,024 - Ali , et al. May 4, 2
2010-05-04
Manufacturing process for tigecycline
Grant 7,705,168 - Chanana , et al. April 27, 2
2010-04-27
Serotonin and norepinephrine reuptake inhibitors and uses thereof
Grant 7,687,520 - Shah , et al. March 30, 2
2010-03-30
Mono- and di-phosphates of 3-(3-fluoro-4-hydroxy-phenyl)-7-hydroxy-naphthalene-1-carbonitrile
Grant 7,649,018 - Fawzi , et al. January 19, 2
2010-01-19
Salicylate and gentisate salts of a piperazine compound
Grant 7,615,551 - Deshmukh , et al. November 10, 2
2009-11-10
Serotonin and norepinephrine reuptake inhibitor and uses thereof
Grant 7,595,340 - Shah , et al. September 29, 2
2009-09-29
Glucuronate salt of a piperazine compound
Grant 7,595,310 - Deshmukh , et al. September 29, 2
2009-09-29
Bazedoxifene Ascorbate
App 20090137559 - Fawzi; Mahdi B. ;   et al.
2009-05-28
Bazedoxifene ascorbate
Grant 7,504,394 - Fawzi , et al. March 17, 2
2009-03-17
Mono-and-di-phosphates Of 3-(3-fluoro-4-hydroxy-phenyl)-7-hydroxy-naphthalene-1-carbonitrile
App 20080214507 - FAWZI; Mahdi B. ;   et al.
2008-09-04
Formulations for parenteral delivery of compounds and uses thereof
App 20080070975 - Shah; Syed M. ;   et al.
2008-03-20
Glucuronate salt of a piperazine compound
App 20070254876 - Deshmukh; Subodh S. ;   et al.
2007-11-01
Methods of treating gastrointestinal tract infections with tigecycline
App 20070243244 - Shah; Syed M. ;   et al.
2007-10-18
Rapamycin polymorphs and uses thereof
Grant 7,282,505 - Zhu , et al. October 16, 2
2007-10-16
Sustained-release formulation and uses thereof
App 20070059366 - Ali; Kadum ;   et al.
2007-03-15
Salicylate and gentisate salts of a piperazine compound
App 20070060580 - Deshmukh; Subodh S. ;   et al.
2007-03-15
Manufacturing process for tigecycline
App 20070026080 - Chanana; Gurmukh ;   et al.
2007-02-01
Highly bioavailable oral delayed release dosage forms of O-desmethylvenlafaxine succinate
App 20070014859 - Shah; Syed M. ;   et al.
2007-01-18
Serotonin and norepinephrine reuptake inhibitor and uses thereof
App 20070015824 - Shah; Syed M. ;   et al.
2007-01-18
Serotonin and norepinephrine reuptake inhibitors and uses thereof
App 20070015791 - Shah; Syed M. ;   et al.
2007-01-18
Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof
App 20070015828 - Shah; Syed M. ;   et al.
2007-01-18
Tigecycline compositons and methods of preparation
App 20060247181 - Fawzi; Mahdi B. ;   et al.
2006-11-02
O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof
App 20060223791 - Shah; Syed M. ;   et al.
2006-10-05
Rapamycin polymorphs and uses thereof
App 20060040971 - Zhu; Tianmin ;   et al.
2006-02-23
Bazedoxifene ascorbate
App 20050227964 - Fawzi, Mahdi B. ;   et al.
2005-10-13
Bazedoxifene acetate formulations
App 20050227966 - Shah, Syed M. ;   et al.
2005-10-13
Multiparticulate O-desmethylvenlafaxine salts and uses thereof
App 20050175698 - Diorio, Christopher Richard ;   et al.
2005-08-11
Novel solid pharmaceutical dispersions
App 20040110694 - Ghebre-Sellassie, Isaac ;   et al.
2004-06-10
Pregnanes
Grant 6,713,465 - Bender , et al. March 30, 2
2004-03-30
Rapamycin dialdehydes
Grant 6,680,330 - Zhu , et al. January 20, 2
2004-01-20
Solid pharmaceutical dispersions
Grant 6,677,362 - Ghebre-Sellassie , et al. January 13, 2
2004-01-13
Rapamycin 29-enols
Grant 6,677,357 - Zhu , et al. January 13, 2
2004-01-13
Amiodarone solutions suitable for intravenous administration
App 20030139468 - Fawzi, Mahdi B. ;   et al.
2003-07-24
Rapamycin 29-Enols
App 20030114477 - Zhu, Tianmin ;   et al.
2003-06-19
Rapamycin dialdehydes
App 20030100577 - Zhu, Tianmin ;   et al.
2003-05-29
Novel solid pharmaceutical dispersions
App 20010044409 - Ghebre-Sellassie, Isaac ;   et al.
2001-11-22
Dual control sustained release drug delivery systems and methods for preparing same
Grant 5,656,296 - Khan , et al. August 12, 1
1997-08-12
Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents
Grant 5,424,301 - Huang , et al. June 13, 1
1995-06-13
Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
Grant 5,373,022 - Fawzi , et al. December 13, 1
1994-12-13
Neutral stabilization complex for CI-979 HCl, a cognition activator
Grant 5,362,860 - Huang , et al. November 8, 1
1994-11-08
Stabilization of enteric coated dosage form
Grant 5,068,110 - Fawzi , et al. November 26, 1
1991-11-26
Methylene pyrrolidone copolymers for contact lens and pharmaceutical preparations
Grant 5,035,884 - Song , et al. July 30, 1
1991-07-30
Oral pharmaceutical composition for acid sensitive proteinaceous agents
Grant 5,032,405 - Huang , et al. July 16, 1
1991-07-16
Water dispersible gemfibrozil compositions
Grant 4,971,804 - Ghebre-Sellassie , et al. November 20, 1
1990-11-20
Purified thrombin preparations
Grant 4,965,203 - Silbering , et al. October 23, 1
1990-10-23
Copolymers from n-alkyl-3-alkenylene-2-pyrrolidone
Grant 4,931,519 - Song , et al. June 5, 1
1990-06-05
Extended release gemfibrozil composition
Grant 4,925,676 - Ghebre-Sellassie , et al. May 15, 1
1990-05-15
Penetration enhancement system
Grant 4,908,389 - Mahjour , et al. March 13, 1
1990-03-13
Fatty acids and their small chain esters as penetration enhancers in aqueous systems
Grant 4,879,297 - Mahjour , et al. November 7, 1
1989-11-07
Transdermal drug delivery device comprising copolymers of N-morpholinoethyl methacrylate and 2-hydroxylmethacrylate
Grant 4,857,313 - Song , et al. August 15, 1
1989-08-15
Tablet
Grant D302,481 - Miller , et al. July 25, 1
1989-07-25
N-substituted-3-alkylene-2-pyrrolidone compounds
Grant 4,851,545 - Song , et al. July 25, 1
1989-07-25
Drug compositions stabilized against oxidation
Grant 4,830,853 - Murthy , et al. May 16, 1
1989-05-16
Lipid regulating agents
Grant 4,814,354 - Ghebre-Sellassie , et al. March 21, 1
1989-03-21
Silicone elastomer transdermal matrix system
Grant 4,814,173 - Song , et al. March 21, 1
1989-03-21
Sustained release pharmaceutical preparations
Grant 4,810,501 - Ghebre-Sellassie , et al. March 7, 1
1989-03-07
Transdermal matrix system
Grant 4,789,547 - Song , et al. December 6, 1
1988-12-06
Use of commercial lecithin as skin penetration enhancer
Grant 4,783,450 - Fawzi , et al. November 8, 1
1988-11-08
Thrombin preparations
Grant 4,696,812 - Silbering , et al. September 29, 1
1987-09-29
Transdermal formulations
Grant 4,666,926 - Mahjour , et al. May 19, 1
1987-05-19
Parenteral phenytoin preparations
Grant 4,642,316 - Fawzi , et al. February 10, 1
1987-02-10
Penetrating topical pharmaceutical compositions containing corticosteroids
Grant 4,552,872 - Cooper , et al. November 12, 1
1985-11-12
Stable radiographic imaging agents
Grant 4,440,738 - Fawzi , et al. April 3, 1
1984-04-03
Topical antimicrobial composition
Grant 4,406,884 - Fawzi , et al. September 27, 1
1983-09-27
Topical antimicrobial anti-inflammatory compositions
Grant 4,343,798 - Fawzi August 10, 1
1982-08-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed